NIH-funded research R01 grant

Improving RNA sequencing accuracy using a novel method

Official title: Twice reading of RNA by direct nanopore sequencing

Funded at Thomas Jefferson University · NIH-11081654 · Data updated 2026-11-12

This study is testing a new way to read RNA more accurately using a special technique that could help us better understand how genes work, which might lead to better tests and treatments for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionThomas Jefferson University
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startMay 1, 2024
Project endFebruary 29, 2028
Funding year2025
Award (this year)$843,060
NIH project number5R01HG013302-02
Project IDNIH-11081654 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions related to gene expression and RNA modifications, such as certain cancers or genetic disorders.

Less likely to help

Patients with conditions unrelated to RNA modifications or those who do not have any genetic disorders may not benefit from this research.

What this research studies

This research focuses on enhancing the accuracy of RNA sequencing by employing a technique called 'twice reading' using a specialized enzyme from the poliovirus. By copying RNA modifications twice, the study aims to provide a more precise mapping of these modifications, which are crucial for understanding gene expression and their roles in health and disease. The approach utilizes advanced nanopore sequencing technology to capture and quantify RNA modifications that are often missed in traditional methods. Patients may benefit from improved diagnostic tools and treatments based on a better understanding of RNA modifications.

Why it matters

Potential benefit: If successful, this research could lead to more accurate diagnostics and targeted therapies for diseases influenced by RNA modifications.

How similar studies have gone: Previous research has shown promise in improving RNA sequencing techniques, but this specific approach of 'twice reading' is relatively novel and untested.

Where this research is happening

  • Thomas Jefferson University
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Hou, Ya-Ming — Thomas Jefferson University
  • Study coordinator: Hou, Ya-Ming

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.